T-lymphocyte profiles in FIV-infected wild lions and pumas reveal CD4 depletion.
ABSTRACT Feline immunodeficiency virus (FIV) is a lentivirus related to human immunodeficiency virus (HIV) that causes feline AIDS in the domestic cat (Felis catus). Serological surveys indicate that at least 25 other species of cat possess antibodies that cross-react with domestic cat FIV. Most infected nondomestic cat species are without major symptoms of disease. Long-term studies of FIV genome variation and pathogenesis reveal patterns consistent with coadaptation of virus and host in free-ranging FIV-Ple-infected African lions (Panthera leo) and FIV-Pco-infected pumas (Puma concolor) populations. This report examined correlates of immunodeficiency in wild and captive lions and pumas by quantifying CD5(+), CD4(+), and CD8(+) T-cell subsets. Free-ranging FIV-Ple-infected lions had immunofluorescence flow cytometry (IFC) profiles marked by a dramatic decline in CD4(+) subsets, a reduction of the CD4(+)/CD8(+) ratio, reduction of CD8(+)beta(high) cells, and expansion of the CD8(+)beta(low) subset relative to uninfected lions. An overall significant depletion in CD5(+) T-cells in seropositive lions was linked with a compensatory increase in total CD5(-) lymphocytes. The IFC profiles were altered significantly in 50% of the seropositive individuals examined. The FIV-Pco-infected pumas had a more generalized response of lymphopenia expressed as a significant decline in total lymphocytes, CD5(+) T-cells, and CD5(-) lymphocytes as well as a significant reduction in CD4(+) T-cells. Like lions, seropositive pumas had a significant decline in CD8(+)beta(high) cells but differed by not having compensatory expansion of CD8(+)beta(low) cells relative to controls. Results from FIV-infected lions and pumas parallel human and Asian monkey CD4(+) diminution in HIV and SIV infection, respectively, and suggest there may be unrecognized immunological consequences of FIV infection in these two species of large cats.
- SourceAvailable from: Michael Podell
- [Show abstract] [Hide abstract]
ABSTRACT: Bovine tuberculosis (BTB), caused by Mycobacterium bovis, is a disease that was introduced relatively recently into the Kruger National Park (KNP) lion population. Feline immunodeficiency virus (FIV(ple)) is thought to have been endemic in lions for a much longer time. In humans, co-infection between Mycobacterium tuberculosis and human immunodeficiency virus increases disease burden. If BTB were to reach high levels of prevalence in lions, and if similar worsening effects would exist between FIV(ple) and BTB as for their human equivalents, this could pose a lion conservation problem. We collected data on lions in KNP from 1993 to 2008 for spatio-temporal analysis of both FIV(ple) and BTB, and to assess whether a similar relationship between the two diseases exists in lions. We found that BTB prevalence in the south was higher than in the north (72 versus 19% over the total study period) and increased over time in the northern part of the KNP (0-41%). No significant spatio-temporal differences were seen for FIV(ple) in the study period, in agreement with the presumed endemic state of the infection. Both infections affected haematology and blood chemistry values, FIV(ple) in a more pronounced way than BTB. The effect of co-infection on these values, however, was always less than additive. Though a large proportion (31%) of the lions was co-infected with FIV(ple) and M. bovis, there was no evidence for a synergistic relation as in their human counterparts. Whether this results from different immunopathogeneses remains to be determined.Proceedings of the Royal Society B: Biological Sciences 08/2012; 279(1745):4206-14. · 5.29 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Environmental transmission of Toxoplasma gondii, a global zoonotic parasite, adversely impacts human and animal health. Toxoplasma is a significant cause of mortality in threatened Southern sea otters, which serve as sentinels for disease threats to people and animals in coastal environments. As wild and domestic felids are the only recognized hosts capable of shedding Toxoplasma oocysts into the environment, otter infection suggests land-to-sea pathogen transmission. To assess relative contributions to terrestrial parasite loading, we evaluated infection and shedding among managed and unmanaged feral domestic cats, mountain lions, and bobcats in coastal California, USA. Infection prevalence differed among sympatric felids, with a significantly lower prevalence for managed feral cats (17%) than mountain lions, bobcats, or unmanaged feral cats subsisting on wild prey (73-81%). A geographic hotspot of infection in felids was identified near Monterey Bay, bordering a high-risk site for otter infection. Increased odds of oocyst shedding were detected in bobcats and unmanaged feral cats. Due to their large populations, pet and feral domestic cats likely contribute more oocysts to lands bordering the sea otter range than native wild felids. Continued coastal development may influence felid numbers and distribution, increase terrestrial pathogens in freshwater runoff, and alter disease dynamics at the human-animal-environment interface.EcoHealth 09/2013; 10(3). · 2.27 Impact Factor
T-LYMPHOCYTE PROFILES IN FIV-INFECTED WILD LIONS AND
PUMAS REVEAL CD4 DEPLETION
M. E. Roelke,1J. Pecon-Slattery,2,8S. Taylor,3S. Citino,4E. Brown,2,7C. Packer,5
S. VandeWoude,6and S. J. O’Brien2
1Laboratory of Genomic Diversity, Basic Research Program, SAIC Frederick, National Cancer Institute, Frederick,
Maryland 21702, USA
2National Cancer Institute–Frederick, Frederick, Maryland 21702, USA
3Environmental Protection Agency, Research Triangle Park, North Carolina 27711, USA
4White Oak Conservation Center, Yulee, Florida 32097, USA
5Department of Ecology, Evolution and Behavior, University of Minnesota, St. Paul, Minnesota 55108, USA
6Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523, USA
7Present address: U.S. Food and Drug Administration, College Park, Maryland 20740, USA
8Corresponding author (email: email@example.com)
ciency virus (HIV) that causes feline AIDS in the domestic cat (Felis catus). Serological surveys
indicate that at least 25 other species of cat possess antibodies that cross-react with domestic cat
FIV. Most infected nondomestic cat species are without major symptoms of disease. Long-term
studies of FIV genome variation and pathogenesis reveal patterns consistent with coadaptation of
virus and host in free-ranging FIV-Ple–infected African lions (Panthera leo) and FIV-Pco–infected
pumas (Puma concolor) populations. This report examined correlates of immunodeficiency in wild
and captive lions and pumas by quantifying CD5+, CD4+, and CD8+ T-cell subsets. Free-ranging
FIV-Ple–infected lions had immunofluorescence flow cytometry (IFC) profiles marked by
a dramatic decline in CD4+ subsets, a reduction of the CD4+/CD8+ ratio, reduction of CD8+bhigh
cells, and expansion of the CD8+blowsubset relative to uninfected lions. An overall significant
depletion in CD5+ T-cells in seropositive lions was linked with a compensatory increase in total
CD52 lymphocytes. The IFC profiles were altered significantly in 50% of the seropositive
individuals examined. The FIV-Pco–infected pumas had a more generalized response of
lymphopenia expressed as a significant decline in total lymphocytes, CD5+ T-cells, and CD52
lymphocytes as well as a significant reduction in CD4+ T-cells. Like lions, seropositive pumas
had a significant decline in CD8+bhighcells but differed by not having compensatory expansion
of CD8+blowcells relative to controls. Results from FIV-infected lions and pumas parallel human
and Asian monkey CD4+ diminution in HIV and SIV infection, respectively, and suggest there
may be unrecognized immunological consequences of FIV infection in these two species of large
CD4 T-cells, Felidae, FIV, flow cytometry, immune depletion, lion, lympho-
Feline immunodeficiency virus (FIV) is a lentivirus related to human immunodefi-
Feline immunodeficiency virus (FIV) is
a pathogenic lentivirus related to human
immunodeficiency virus (HIV) and simian
immunodeficiency virus (SIV). Initially
isolated in 1986, FIV was subsequently
identified as the etiologic agent of ac-
quired immune deficiency syndrome or
feline AIDS in the domestic cat (Felis
catus) (Pedersen et al., 1987; Brunner and
Pedersen, 1989; Pedersen et al., 1989;
Gardner, 1991). Feline immunodeficiency
virus–infected domestic cats exhibit dis-
ease symptoms, immune suppression, and
mortality markedly similar to HIV in-
fection in humans (Yamamoto et al.,
1988; Pedersen et al., 1989; Yamamoto et
al., 1989; Willett et al., 1993; English et al.,
1994; Bendinelli et al., 1995; Liang et al.,
2000). Feline immunodeficiency virus
strains are species-specific as indicated
by comparative genomic analyses of
strains sequenced from domestic cats
(FIV-Fca), Pallas cats (Otocolobus manul;
FIV-Oma), cheetahs (Acinonyx jubatus;
FIV-Aju), leopards (Panthera pardus;
FIV-Ppa), pumas (Puma concolor; FIV-
Pco), and African lions (Panthera leo; FIV-
Ple) (Brown et al., 1994; Carpenter et al.,
1996, 1998; Troyer et al., 2005). Additional
serological surveys indicate at least 25
Journal of Wildlife Diseases, 42(2), 2006, pp. 234–248
#Wildlife Disease Association 2006
other species of cats possess antibodies
that cross-react with FIV (Olmsted et al.,
1992; Brown et al., 1994; Carpenter and
O’Brien, 1995; Carpenter et al., 1996,
1998; Troyer et al., 2004, 2005). The
observed worldwide prevalence of FIV in
multiple cat species is made more in-
triguing by the apparent lack of discern-
able disease in nondomestic cat species
(Lutz et al., 1992; Hofmann-Lehmann et
al., 1996; Packer et al., 1999), although an
FIV-positive captive lion with end-stage
disease reminiscent of domestic cats with
feline AIDS has been reported (Poli et al.,
1995; Bull et al., 2003).
Phylogenetic studies of the gag and pol
genes from FIV in natural populations of
pumas in North and South America and
African lions in eastern and southern
Africa and env regions from FIV-Fca
sampled from domestic cats worldwide
depict unique patterns of virus-host co-
evolution. In pumas, FIV-Pco forms dis-
tinct divergent evolutionary lineages that
are distributed throughout this species
range (Carpenter et al., 1996; Biek et al.,
2003). In lions, FIV-Ple is endemic to
populations within east and south Africa
and forms at least three different evolu-
tionary clades with high levels of genetic
differences (Brown et al., 1994; Troyer et
al., 2004, 2005). Genetic analyses of FIV-
Ple within a large out-bred population of
lions in the Serengeti region of Tanzania
revealed .90% prevalence with 43% of
the individuals multiply infected with at
least two subtypes (Brown et al., 1994;
Troyer et al., 2004). In domestic cats, FIV-
Fca subtype classification is made using
the more variable env region rather than
the pol or gag analyzed in FIV from other
species. Even using the env region, FIV-
Fca has lower levels of intersubtype
divergence than FIV-Pco and FIV-Ple
(Carpenter et al., 1998). Further, three
of the five recognized subtypes or clades
of FIV-Fca are composed of closely re-
lated strains from cats dwelling on differ-
ent continents (Carpenter et al., 1998).
Thus, the low genetic diversity and de-
monstrable pathogenicity of FIV in do-
mestic cats suggest that this species
acquired FIV relatively recently, whereas
FIV-Pco and FIV-Ple descend from an
earlier species experience with endemic
virus and became attenuated as a natural
outcome of a longer period of virus-host
coevolution (Carpenter and O’Brien,
1995; Carpenter et al., 1996, 1998).
Under this scenario, FIV-Fca, FIV-Ple,
and FIV-Pco would be expected to elicit
different clinicopathologic abnormalities
in their respective host species. However,
evaluation of such parameters using a sys-
tematic approach in lions and pumas has
been impeded by logistical difficulties and
infrequent opportunities associated with
sample collection in the wild, adequate
preservation of samples in field conditions,
and lack of reagents or reagent validation
to measure blood cell responses for exotic
felids accurately. Consequently, only one
previously published study has reported
lymphocyte subset alterations in five
captive FIV-Ple seropositive lions (Bull
et al., 2003) Additionally, the high ser-
oprevalence rate of some free-ranging
populations (up to 100%) (Brown et al.,
1994; Carpenter and O’Brien, 1995; Biek
et al., 2003; Troyer et al., 2004) may affect
statistical analyses of seropositive versus
Analysis of domestic cats infected with
FIV-Fca, on the other hand, has been
more intensively studied. Domestic cats
infected with FIV-Fca experience pro-
found changes in T-cell subsets concur-
rent with clinical immune deficiency. Like
HIV in humans, the continued deteriora-
tion of the host immune system in FIV-
positive domestic cats is correlated with
the reduction in circulating CD4+ lym-
phocytes (Ackley et al., 1990; Novotney et
al., 1990). In the initial acute phase, the
CD4+/CD8+ ratio is lowered as a conse-
quence by both the reduction of CD4+ T-
cells and the marked expansion of CD8+
T-cells (Willett et al., 1993). However,
subtype and/or strain-specific effects on
the host circulating lymphocyte kinetics,
ROELKE ET AL.—T-LYMPHOCYTE PROFILES IN LIONS AND PUMAS235
which parallels the degree of immunosup-
pression or virulence, are observed in
domestic cats infected with a less virulent
strain of FIV characterized by low viral
load (Hosie et al., 2002). Experimental
infection of domestic cats with FIV-Pco or
FIV-Ple results in apathogenic but pro-
ductive infection (VandeWoude et al.,
1997a, b, 2003; Terwee et al., 2005),
which strengthens the hypothesis that
nondomestic cat FIVs are host-adapted
or perhaps less virulent lentiviruses.
We examined changes in T-cell lym-
phocytes in response to FIV infection in
a cohort of both captive and free-ranging
populations of lions and pumas and found
significant changes in circulating lympho-
cyte T-cell subsets associated with FIV
infection. These findings may have signif-
icant implications for management of FIV-
positive endangered feline species and for
the health of individual animals.
Study animals: pumas and lions
The FIV-positive and -negative individ-
uals were sampled from pumas in North
America and African lions from the
Serengeti National Park in Tanzania and
Kruger National Park in South Africa
(Table 1). All pumas and free-ranging
African lions were captured, anesthetized,
examined, and bled as part of ongoing
field studies (Roelke et al., 1993; Roelke-
Parker et al., 1996). The puma sample
consisted of 10 uninfected individuals (1–
9 yr-old) and six FIV-Pco–infected ani-
mals (5–12 yr-old); five were captive, and
11 were free-ranging, all originating from
the same population in southern Florida,
USA. Twelve FIV-Ple–infected lions (2–
12 yr-old) and five zoo-bred captive naive
lions of unknown ages with no record of
ancestral geographic origin were sampled.
All seropositive lions were free-ranging in
either Kruger National Park, South Africa,
or Serengeti National Park, Tanzania.
Captive lions were bled during routine
yearly physical examinations.
Sample collection and processing
Peripheral whole blood collected from
both captive and free-ranging animals was
processed within 48 hr. Whole blood
collected with EDTA was used for an
absolute white blood cell count (WBC),
determined by the UnopipetteH counting
system and hemocytometer, and an abso-
lute lymphocyte count, determined by
staining blood films with a modified
Wright-Giemsa stain. To process samples
for lymphocyte analyses, peripheral blood
mononuclear cells (PBMCs) were sepa-
rated from whole anticoagulated blood
collected by using Histopaque-1077 (Sig-
ma, St. Louis, Missouri, USA) and viably
frozen. Five milliliters of whole blood was
overlaid on 5 ml histopaque and spun at
400 3 G for 30 min. The PBMC layer was
removed, washed in phosphate buffered
saline (PBS), and spun at 250 3 G for
10 min at least twice. Cell pellets were
gently suspended in 90% fetal calf serum
with 10% dimethyl sulfoxide (DMSO) and
viably frozen, in aliquots of 107cells/ml/
cryotube, at a rate of 1 C/min and stored
in liquid nitrogen.
Serum samples were simultaneously
collected and screened for antibodies to
both FIV-Pco and FIV-Ple antigens.
Western blot analysis for FIV-reacting
antibodies was performed as previously
described (Diehl et al., 1995; Vande-
Woude et al., 1997a, b; Troyer et al.,
2005). Tissue culture supernatant contain-
ing either virus strain grown on 3201
T-cells was concentrated by ultracentrifu-
gation. Protein content was determined,
and viral antigen was subjected to poly-
acrylamide electrophoresis and trans-
ferred to nylon membranes. Diluted
serum was reacted with membrane strips,
and bound antibody detected by horse
radish peroxidase-labeled secondary anti-
bodies. To ensure FIV antibody detection,
FIV-Fca antigen was used in separate tests
in addition to FIV-Pco for pumas and
FIV-Ple for lions. Positive and negative
sera served as controls for comparison to
236JOURNAL OF WILDLIFE DISEASES, VOL. 42, NO. 2, APRIL 2006
TABLE 1. Species, identity, health status, origin and contact for samples used in this study.
Puma (Puma concolor)
PCO-1668 Aug 1991
M5 Captive HealthyEverglades Holiday
Big Cypress Swamp,
Big Cypress Swamp,
Big Cypress Swamp,
Big Cypress Swamp,
Big Cypress Swamp,
Big Cypress Swamp,
White Oak Planta-
PCO-387 6 Aug 1991
M9Captive HealthyM. Roelke
PCO-390 6 Aug 1991
F8 CaptiveHealthyM. Roelke
PCO-3927 Aug 1991
M7Captive Healthy M. Roelke
PCO-533 16 Dec 1996 2
M5 Wild Healthy S. Taylor/D.
PCO-539 15 Jan 1997
PCO-717 8 Mar 1997
PCO-718 18 Mar 1997 2
PCO-719 15 Apr 1997 2
PCO-898 5 Mar 1997
PCO-075 14 Jan 1997
F 12Captive Anemia,
Healthy PCO-154 25 Jan 1992
M5WildBig Cypress Swamp,
Big Cypress Swamp,
Big Cypress Swamp,
Big Cypress Swamp,
Big Cypress Swamp,
PCO-160 21 Feb 1997
F 10Wild Mange
PCO-730 18 Dec 1996
PCO-733 19 Dec 1996
PCO-736 10 Jan 1997
African lion (Panthera leo)
PLE-030 5 Feb 1997
M3Captive HealthyWildlife Waystation,
Druid Park Zoo, Bal-
Kruger National Park,
Kruger National Park,
Kruger National Park,
Kruger National Park,
PLE-031 28 Feb 1997 2
M n/aCaptiveHealthyR. Yates
PLE-032 28 Feb 1997 2
PLE-0337 Mar 1997
F9 CaptiveAsthmaM. Cranfield
PLE-0341 Apr 1997
PLE-133 26 July 1992
PLE-134 27 July 1992
PLE-135 26 July 1992
PLE-138 27 July 1992
ROELKE ET AL.—T-LYMPHOCYTE PROFILES IN LIONS AND PUMAS237
Immunofluorescence flow cytometry
Viably frozen PBMCs were quickly
thawed at 37 C, washed in PBS, counted,
and resuspended in a buffer solution of
PBS. The PBMCs (13106) were com-
bined in separate tubes with monoclonal
antibodies that recognize the following:
feline CD4+ (Fel7 clone CD4; Klotz and
Cooper, 1986; Ackley et al., 1990); feline
CD8+ (FT2 clone fCD8-Beta; Klotz and
Cooper, 1986); and feline Pan-T+ cell
CD5 equivalent (clone f43; Ackley and
Cooper, 1992). The T-cell profiles were
generated by double labeling with CD5+/
CD4+, CD5+/CD8+, or CD4+/CD8+ and
quantified by two-color immunofluores-
cence flow cytometry (IFC) using Becten-
Dickenson FACscan and Cell Quest
software. A dot-plot of side and forward
scatter was used to construct a live lym-
phocyte gate of 5,000–10,000 cells per
assay. The absolute number of T-cells
was determined by multiplying the frac-
tion of respective CD4+, CD8+, and
CD5+ subpopulations times the number
of lymphocytes/ml within the original
sample. The CD52 cells, within the gated
lymphocyte fraction, were considered
primarily B cells, though it is possible that
this fraction could also contain small
proportions of monocytic cells. No con-
version values were available for lions
sampled from Kruger Park (Ple 133, 134,
135, 138). The potential bias introduced
by using viably frozen PBMC versus those
from fresh blood for IFC was addressed
by setting the gates to exclude nonspecific
binding and thus compensate for back-
ground staining due to cell death. More-
over, IFC analysis provided comparable
results whether performed on frozen or
fresh PBMC in our experience (Vande-
Woude, unpublished data) as well as that
of others (Bull et al., 2003).
PLE-569 28 June 1994
F3Wild Chronic CDV
Acute CDV infec-
PLE-5861 Apr 1994
PLE-599 20 July 1994
F13 WildSerengeti National
PLE-605 19 July 1995
PLE-6187 July 1994
F4Wild Prior CDV infec-
PLE-645 18 Mar 1995
F 8 to 10Wild Serengeti National
PLE-647 10 July 1995
M 6 to 8 WildSerengeti National
PLE-64917 Jan 1996
M 6 to 8 Wild Serengeti National
aFIV status determined by Western blot (see Methods).
bRemoved from the wild in 1987.
238 JOURNAL OF WILDLIFE DISEASES, VOL. 42, NO. 2, APRIL 2006
The total T-cell (CD5+) profile gener-
ated by IFC displayed the relative propor-
tions of CD4+, CD8+, and CD42CD82
subpopulations within the PBMC sample.
These ratios were not independent be-
cause they were derived from the total
CD5+ T-cells; therefore, we performed
heterogeneity G-tests (Sokol and Rohlf,
1991). Each profile was tested against the
expected profile from control naive ani-
mals to determine if the individual T-cell
subset profile changed with FIV infection.
Significance was determined by computa-
tion of a G-statistic that approximates a chi
For each IFC profile, the relative
proportions of CD4+, CD8+, and CD42
CD82CD5+ cells were converted into
absolute numbers of cells based on the
absolute cell count of lymphocytes. We
evaluated the following absolute cell
counts for each animal: WBC/ml, total
lymphocytes/ml, total CD52 cells/ml,
CD5+ T-cells/ml, CD4+/ml, CD8+/ml,
and CD42CD82CD5+/ml. In addition,
we examined two subsets, CD8+blowand
CD8+bhigh, identified by the antibody FT2
as it binds specifically to the beta chain of
the CD8+ heterodimer molecule. Esti-
mates of cell counts for each were com-
puted by multiplying the relative pro-
portion times the estimated CD8+ cells/
ml count for each individual.
The distribution of each cell count
variable was tested for normality using
the Shapiro-Wilks’ W suitable for small
sample sizes. The relative impact of FIV
status on the cell count variables for each
species was tested using analysis of
variance (ANOVA) and paired t-tests of
means (SAS, 2001).
The majority of lymphocytes of 17 lion
and 16 puma blood samples were CD5+
T-cells by IFC. The relative proportion of
CD4+, CD8+, and CD42CD82 subsets
among CD5+ T-lymphocytes were de-
termined and presented as a CD5+ T-cell
profile per animal (Table 2). Further, cell
count data were used to test for changes in
WBC/ml, total lymphocytes/ml, total
CD52 cells/ml, CD5+ T-cells/ml, CD4+
cells/ml, CD8+ T-cells/ml, CD8bhigh/ml,
cells/ml. Shapiro-Wilks’ W test indicated
normal distributions for each of these cell
count variables. Two of these variables,
WBC/ml and CD8+ T-cells/ml, did not
change with FIV status in either lions or
pumas (Table 3; Figs. 1a, b).
T-cell alterations with FIV infection in pumas
The IFC profiles of the relative propor-
tions of CD4+, CD8+, and CD42CD82
CD5+ cells within FIV-negative pumas
were uniform among individuals (G-test,
NS). The mean T-cell profile for pumas
infected with FIV-Pco was 42:27:29 (per-
centage of CD4+, CD8+, and CD42
CD82CD5+, respectively). Three of the
six FIV-Pco–infected pumas (Pco-075,
Pco-733, and Pco-736) had significant
differences in IFC profiles (Table 2), but
the overall mean profile for positive
animals was not significantly altered
relative to negative controls (G-test,
Infection with FIV-Pco was correlated
with an overall reduction in cell counts
of total lymphocytes (t-test, P50.03) that
involved both CD5+ T-cells and CD52
lymphocyte subsets and was accompa-
nied by a 50% reduction in CD4+ cells/
ml relative to uninfected pumas (t-test,
P50.008) (Table 3 and Fig. 1a). No
significant changes were observed in
the CD8+ and CD42CD82CD5+ T-
cell subsets relative to the negative
controls (Tables 2 and 3). Further exam-
ination of the CD8+ T-cell subset
revealed no change in CD8+blowcells,
CD8+bhighcells was detected with FIV-
Pco infection (t-test, P5 0.008) (Table 3
and Fig. 2a, b).
ROELKE ET AL.—T-LYMPHOCYTE PROFILES IN LIONS AND PUMAS239
T-cell alterations with FIV infection in lions
Homogeneous IFC profiles of uninfect-
ed lion controls had an average ratio of
60 : 22 : 18 for relative CD4+, CD8+, and
CD42CD82CD5+ percentages. In con-
trast, IFC profiles for infected lions were
P59.031029), and each had significant
deviation from the mean profile (G-test,
P52.531025) (Table 2).
Measured cell counts indicated total
lymphocytes did not vary with FIV-Ple
infection as observed with FIV-Pco in
pumas (Table 3 and Fig. 1b). Instead,
infected lions had both a significant
Immunofluorescent profiles of lymphocytes in FIV infected pumas and lions and uninfected
Species ID FIV
Proportion of CD5+
Proportion of CD8b+ (%)Ratio
Puma (Puma concolor)
African lion (Panthera leo)
aDenotes individuals with significantly different IFC profile from mean profile of control animals.
240JOURNAL OF WILDLIFE DISEASES, VOL. 42, NO. 2, APRIL 2006
Absolute cell counts standardized by total T-cell counts (see Methods, Table 2).
Absolute cell counts (103/ml)
Estimated Cell Counts (103/ml)
Puma (Puma concolor)
LION (Panthera leo)
ROELKE ET AL.—T-LYMPHOCYTE PROFILES IN LIONS AND PUMAS 241
P50.0025) and a dramatic 80% decline in
CD4+ cells (t-test, P50.0001) relative to
controls (Fig. 1b). This CD4+ cell decline
was observed without a significant in-
crease in overall CD8+ levels. However,
within the CD8+ subset, bhighcells de-
clined precipitously with FIV-Ple infection
to one-third the levels observed in controls
(t-test, P50.006) and was accompanied by
an expansion of blowcells (t-test, P50.03)
(Fig. 2a, b). Further unique changes were
observed including an increase in the cell
counts of the CD42CD82CD5+ subset
(t-test, P50.05) and an increase in the
CD52 lymphocytes (t-test, P50.001),
presumed to be mostly B cells, in infected
lions relative to negative controls (Table 3
and Fig. 1b).
Alteration of the CD4+/CD8+ ratio with FIV infection
Both lions and pumas were examined
for reduction of the CD4+/CD8+ ratio
commonly observed in FIV-Fca infection
of domestic cats. In lions, the CD4+/
mean52.95 (range of 2.23–5.04) in con-
trols to mean51.17 (range of 0.21–2.57) in
FIV-Ple–infected individuals (Table 2). In
contrast, the puma CD4+/CD8+ T-cell
ratio was not significantly altered (Ta-
ble 2) with values slightly less in pumas
with FIV-Pco mean51.73 (range of 0.91–
2.57) compared with mean51.93 (range of
1.37–2.92) in negative animals. The drop
in CD4+ cells in positive pumas was
accompanied by a proportional, albeit
not significant, reduction in CD8+ cells
(Fig. 1b) sufficient to maintain the CD4+/
CD8+ ratio as unchanging with FIV-Pco
To understand the interaction between
FIV and target cells in the host immune
system, we examined T-lymphocyte pro-
files in free-ranging and captive lions and
pumas naturally infected with species-
specific strains FIV-Ple and FIV-Pco,
respectively. The uninfected controls of
the two species had only minor differences
in the relative mean proportions of
subsets (51:27:22 in pumas; 60:22:18 in
lions). However, FIV infection appeared
to affect lions and pumas differently,
causing marked changes in lymphocytes
unique to each species. The T-cell subset
profile perturbations were more pro-
nounced in lions than pumas with FIV
infection. Specifically, all seropositive
lions, but only 50% of FIV-infected
pumas, had significantly altered IFC
profiles relative to negative controls.
The major alteration in the relative
proportion and absolute cell count of
CD4+, CD8+, and CD42CD82 subsets
in both seropositive lions and pumas was
a reduction in CD4+ T-cells. In domestic
cats infected with FIV-Fca, the CD4+/
CD8+ ratio declines during the asymp-
tomatic phase from two or more to less
than one (English et al., 1994; Bendinelli
et al., 1995;) because of CD4+ depletion
concurrent with relative or absolute CD8+
increase. The magnitude of CD4+ de-
pletion was profound in FIV-Ple lions and
resulted in a sharp decline in the CD4+/
CD8+ ratio. By contrast, the CD4+/CD8+
ratio was not significantly altered in pumas
even though FIV-Pco infection was corre-
lated with a 50% decline in CD4+ T-cells.
Additional differences between lions
and pumas included alterations of total
lymphocytes and CD5+ T-cells; neither of
these changes paralleled the typical find-
ings in domestic cats. For example, pumas
infected with FIV-Pco had relative lym-
phopenia, indicated by the 41% lower
total lymphocyte count, which was distrib-
uted equally between CD5+ and CD52
cell subsets. Although lymphopenia was
not noted in seropositive lions (Fig. 1b),
a significant decrease (48%) in CD5+ T-
cells was accompanied by a compensatory
increase in CD52 lymphocytes that
masked this loss. Most studies have not
recorded lymphopenia or pan-T-cell loss
as a striking finding in domestic cat FIV
infection. Therefore, assuming CD52
242JOURNAL OF WILDLIFE DISEASES, VOL. 42, NO. 2, APRIL 2006
cells are predominantly B-cells, this in-
crease would be a unique feature to FIV-
Ple infection as B-cell lymphocyte kinetics
in FIV-Fca infected cats have not been
reported to be altered relative to naive
controls (Ackley et al., 1990; Novotney et
Reduction in CD4+ cells in lions and
pumas was not accompanied by an abso-
lute increase of CD8+ cells as observed in
domestic cats. During the acute and
asymptomatic phases of FIV infection,
CD8+ T-cells are both cytotoxic and
virus-suppressive in domestic cats (Prince
et al., 1991; English et al., 1994). In
particular, the heterodimer CD8+ mole-
cule exhibits changes in the composite
a and b chains correlated with time course
of viral infection, antiviral activity, and
pathogenesis of disease (Shimojima et al.,
1998). The CD8+ subset changes in lions
and pumas in this study were based on the
FT-2 antibody that binds exclusively to the
b chain of the heterodimer. Previous
studies of the CD8+ b chain in the
asymptomatic phase of FIV infection in
CD8+bhighcells and the appearance and
expansion of CD8+blowT cells, which
secrete a soluble factor inhibitory for in
vitro FIV infection (Bucci et al., 1998a, b;
Shimojima et al., 1998; Gebhard et al.,
1999). This simultaneous expansion of
CD8+blowT-cell subsets offsets a decrease
in total CD5+ T-cells with FIV-Fca in-
fection (Willett et al., 1993). In this study,
lions and pumas resembled domestic cats
by having a significant depletion of
cells and a reduction of
CD5+ cells, but only lions had a concom-
itant expansion of CD8+blowcells. A
similar result in a study of five seropositive
captive lions with an expanded CD8+blow
subset relative to naive animals (Bull et al.,
2003) suggests this is a signature of FIV-
Ple infection. Results from FIV-Pco–
infected pumas demonstrated a decline
in lymphocytes in general, and CD4+ cells
in particular, which was not offset by
expansion of any subset presented here.
Rather, a substantial number of CD8+blow
cells are present in pumas irrespective of
FIV status. Perhaps these cells are part of
an immune response to another unspeci-
fied pathogen, or this may reflect the
outcome of coevolution of virus and host
that has resulted in a ‘‘standing army’’
within the species as a whole.
The changes in CD4+ subpopulations in
lions and to a lesser extent in pumas in
response to FIV infection provide strong
support for T-cell dyscrasia as observed
with domestic cats. Yet other lymphocyte
changes specific to lions and pumas
suggest that additional immune responses
occur in both species, and perhaps clues
reside within an uncharacterized T-cell
population present within the CD42
CD82 subset. Although pumas showed
no change in CD42CD82 cell counts
with FIV-Pco infection, FIV positive lions
had a significant increase relative to
controls. Thus, the more muted immune
response of pumas consisting of general
lymphopenia and reduction of CD4+ cells
not accompanied by a change in the
causes less T-cell perturbation in pumas
than FIV-Ple in lions. The FIV-Ple elicits
a dramatic decline in CD4+ cells, yet lions
may be in the process of coadapting to the
virus, as suggested by the unique combi-
nation of increased CD52 cells, expansion
of the CD8+blowsubset, and increased
numbers of CD42CD82 cells.
Alternatively, extreme changes in CD4+
levels in lions also may be influenced by
other determinants such as length of FIV
infection or other microbial infections, as
well as relative binding affinities of mono-
clonal antibodies originally developed for
domestic cat T-cell antigens. The highly
heterogeneous IFC profiles observed
among individual wild seropositive lions
relative to the more uniform profiles of
control lions in zoos might reflect stress
differences between captive and free-
ranging populations. The fact that FIV
status increases with age, and is seen
with high seroprevalence in many free-
ROELKE ET AL.—T-LYMPHOCYTE PROFILES IN LIONS AND PUMAS243
244JOURNAL OF WILDLIFE DISEASES, VOL. 42, NO. 2, APRIL 2006
ranging populations of lions (Brown et al.,
1994; Troyer et al., 2004), also makes it
difficult to determine how age and envi-
ronmental conditions may have contribut-
edtoour findings. Wewereunabletoassess
the effect of age in this study because of
insufficient replicates per age class and
unknown ages for some of both positive and
animals. Boxed regions reflect 25th–75th percentile range of individual values. Bars represent 10th–90th
percentile range. Means are plotted as white line within boxes. P-values are t-test of mean between FIV
positive (puma n56; lion n 5 12) and negative (puma n510; lion n55) animals within each species:
(a) CD8+bhighin pumas and lion, (b) CD8+blowin lions and pumas.
Comparison of CD8+ subsets bhighand blowestimated cell counts in FIV-positive and -negative
cells, total CD5+ T-cells, and T-cell subpopulations from whole blood between FIV-positive and FIV-negative
individuals. (a) Puma positive n56; puma negative n510. (b) Lion positive n512; lion negative n55.
Comparison of mean cell counts (3103/ml) of absolute lymphocytes and estimated total CD52
ROELKE ET AL.—T-LYMPHOCYTE PROFILES IN LIONS AND PUMAS 245
negative lions, leading to a prohibitively
small sample for statistical analysis.
Overall, this immunological survey of
naturally FIV-infected animals may serve
as an indictor of the susceptibility of both
captive and wild populations to emerging
disease. Outbreaks of opportunistic infec-
tions, each with varying degrees of path-
ogenicity, have been documented in non-
domestic species of cat. In lions, a canine
distemper virus (CDV) outbreak caused
significant mortality in free-ranging FIV-
infected African lions of the Serengeti
ecosystem in 1994 (Roelke-Parker et al.,
1996) although other CDV outbreaks in
the same seropositive populations had
negligible mortality (Packer et al., 1999).
In pumas, a recent outbreak of feline
leukemia virus has been linked with, but
no causality yet established for, the deaths
of a small number of seropositive Florida
panthers (M. Cunningham, unpubl. data).
The precise role of FIV in regulating
immune response to such opportunistic
infection remains unknown, yet the T-cell
changes observed in FIV-infected lions
and pumas in this study suggest that
further investigation is warranted and that
it would be prudent to discourage the
translocation of seropositive animals into
We thank Catherine Hageman for assis-
tance in western blot assays and Kathleen
Noer for expertise in IFC analysis. We thank
our colleagues W. Johnson, J. Rossio, G. Bar-
Gal, J. Troyer, M. Cunningham, and D. Land.
All tissue samples were collected in full
compliance with specific Federal Fish and
Wildlife permits: Convention of International
Trade in Endangered Species of Wild Flora
and Fauna (CITES) and Endangered and
Threatened Species, Captive Bred issued to
the National Cancer Institute–National Insti-
tutes of Health (S. J. O’Brien, principal officer)
by the US Fish and Wildlife Service of the
Department of the Interior. This publication
has been funded in whole or in part with
federal funds from the National Cancer In-
stitute, National Institutes of Health, under
contract number N01-CO-12400. The content
of this publication does not necessarily reflect
the views or policies of the Department of
Health and Human Services, nor does men-
tion of trade names, commercial products, or
organizations imply endorsement by the US
Government. This research was supported (in
part) by the Intramural Research Program of
the NIH, National Cancer Institute, Center
for Cancer Research. This material is based
upon work supported by the National Science
Foundation under grant 0343960. Collection
of Serengeti lion samples funded in part by
Messerli Foundation, Zurich, Switzerland.
ACKLEY, C. D., AND M. D. COOPER. 1992. Character-
ization of a feline T-cell-specific monoclonal
antibody reactive with a CD5-like molecule.
American Journal of Veterinary Research 53:
———, J. K. YAMAMOTO, N. LEVY, N. C. PEDERSEN,
AND M. D. COOPER. 1990. Immunologic abnor-
malities in pathogen-free cats experimentally
infected with feline immunodeficiency virus.
Journal of Virology 64: 5652–5655.
BENDINELLI, M., M. PISTELLO, S. LOMBARDI, A. POLI,
C. GARZELLI, D. MATTEUCCI, L. CECCHERINI-
NELLI, G. MALVALDI,
Feline immunodeficiency virus: An interesting
model for AIDS studies and an important cat
BIEK, R., A. G. RODRIGO, D. HOLLEY, A. DRUMMOND,
C. R. ANDERSON, JR., H. A. ROSS, AND M. POSS.
evolution of endemic feline immunodeficiency
virus in a population of wild cougars. Journal of
Virology 77: 9578–9589.
BROWN, E. W., N. YUHKI, C. PACKER,
O’BRIEN. 1994. A lion lentivirus related to feline
phylogenetic aspects. Journal of Virology 68:
BRUNNER, D., AND N. C. PEDERSEN. 1989. Infection of
peritoneal macrophages in vitro and in vivo with
feline immunodeficiency virus. Journal of Virol-
ogy 63: 5483–5488.
BUCCI, J. G., R. V. ENGLISH, H. L. JORDAN, T. A.
CHILDERS, M. B. TOMPKIN, AND W. A. TOMPKINS.
1998a. Mucosally transmitted feline immunode-
ficiency virus induces a CD8+ antiviral response
that correlates with reduction of cell-associated
virus. Journal of Infectious Diseases 177: 18–25.
———, D. H. GEBHARD, T. A. CHILDERS, R. V.
ENGLISH, M. B. TOMPKINS, AND W. A. TOMPKINS.
1998b. The CD8+ cell phenotype mediating
antiviral activity in feline immunodeficiency
virus-infected cats is characterized by reduced
surface expression of the CD8 beta chain.
Journal of Infectious Diseases 178: 968–977.
AND F. TOZZINI. 1995.
AND S. J.
246JOURNAL OF WILDLIFE DISEASES, VOL. 42, NO. 2, APRIL 2006
BULL, M. E., D. G. GEBHARD, W. A. TOMPKINS, AND S.
KENNEDY-STOSKOPF. 2002. Polymorphic expres-
sion in the cd8alpha chain surface receptor of
African lions (Panthera leo). Veterinary Immu-
nology Immunopathology 84: 181–189.
———, S. KENNEDY-STOSKOPF, J. F. LEVINE, M.
LOOMIS, D. G. GEBHARD, AND W. A. TOMPKINS.
2003. Evaluation of T lymphocytes in captive
African lions (Panthera leo) infected with feline
immunodeficiency virus. American Journal of
Veterinary Research 64: 1293–1300.
CARPENTER, M. A., E. W. BROWN, M. CULVER, W. E.
JOHNSON, J. PECON-SLATTERY, D. BROUSSET, AND
S. J. O’BRIEN. 1996. Genetic and phylogenetic
divergence of feline immunodeficiency virus in
the puma (Puma concolor). Journal of Virology
———, ———, D. W. MACDONALD,
O’BRIEN. 1998. Phylogeographic patterns of
feline immunodeficiency virus genetic diversity
in the domestic cat. Virology 251: 234–243.
———, AND S. J. O’BRIEN. 1995. Coadaptation and
Felidae. Current Opinions in Genetics and
Development 5: 739–745.
DIEHL, L. J., C. K. MATHIASON-DUBARD, L. L. O’NEIL,
L. A. OBERT, AND E. A. HOOVER. 1995. Induction
of accelerated feline immunodeficiency virus
disease by acute-phase virus passage. Journal of
Virology 69: 6149–6157.
ENGLISH, R. V., P. NELSON, C. M. JOHNSON, M.
NASISSE, W. A. TOMPKINS, AND M. B. TOMPKINS.
1994. Development of clinical disease in cats
experimentally infected with feline immunode-
ficiency virus. Journal of Infectious Diseases
GARDNER, M. B. 1991. Simian and feline immuno-
deficiency viruses: Animal lentivirus models for
evaluation of AIDS vaccines and antiviral agents.
Antiviral Research 15: 267–286.
GEBHARD, D. H., J. L. DOW, T. A. CHILDERS, J. I.
ALVELO, M. B. TOMPKINS, AND W. A. TOMPKINS.
1999. Progressive expansion of an l-selectin-
negative CD8 cell with anti-feline immunodefi-
ciency virus (FIV) suppressor function in the
circulation of FIV-infected cats. Journal of
Infectious Diseases 180: 1503–1513.
HOFMANN-LEHMANN, R., D. FEHR, M. GROB, M.
ELGIZOLI, C. PACKER, J. S. MARTENSON, S. J.
AND H. LUTZ. 1996. Prevalence of
antibodies to feline parvovirus, calicivirus, her-
pesvirus, coronavirus, and immunodeficiency
virus and of feline leukemia virus antigen and
the interrelationship of these viral infections in
free-ranging lions in east Africa. Clinical Di-
agnostic Laboratory Immunology 3: 554–562.
HOSIE, M. J., B. J. WILLETT, D. KLEIN, T. H.
DUNSFORD, C. CANNON, M. SHIMOJIMA, J. C.
AND O. JARRETT. 2002. Evolution of
replication efficiency following infection with
AND S. J.
a molecularly cloned feline immunodeficiency
virus of low virulence. Journal of Virology 76:
KLOTZ, F. W., AND M. D. COOPER. 1986. A feline
thymocyte antigen defined by a monoclonal
antibody (ft2) identifies a subpopulation of
non-helper cells capable of specific cytotoxicity.
Journal of Immunology 136: 2510–2514.
LIANG, Y., L. C. HUDSON, J. K. LEVY, J. W. RITCHEY,
W. A. TOMPKINS, AND M. B. TOMPKINS. 2000. T
cells overexpressing interferon-gamma and in-
terleukin-10 are found in both the thymus and
secondary lymphoid tissues of feline immuno-
deficiency virus-infected cats. Journal of In-
fectious Diseases 181: 564–575.
LUTZ, H., E. ISENBUGEL, R. LEHMANN, R. H. SABAPARA,
AND C. WOLFENSBERGER. 1992. Retrovirus infec-
tions in non-domestic felids: Serological studies
and attempts to isolate a lentivirus. Veterinary
Immunology and Immunopathology 35: 215–
NOVOTNEY, C., R. V. ENGLISH, J. HOUSMAN, M. G.
DAVIDSON, M. P. NASISSE, C. R. JENG, W. C.
DAVIS, AND M. B. TOMPKINS. 1990. Lymphocyte
population changes in cats naturally infected
with feline immunodeficiency virus. AIDS 4:
OLMSTED, R. A., R. LANGLEY, M. E. ROELKE, R. M.
GOEKEN, D. ADGER-JOHNSON, J. P. GOFF, J. P.
ALBERT, C. PACKER, M. K. LAURENSON, T. M.
CARO, L. SCHEEPERS, D. E. WILDT, M. BUSH, J. S.
MARTENSON, AND S. J. O’BRIEN. 1992. Worldwide
prevalence of lentivirus infection in wild feline
species: Epidemiologic and phylogenetic as-
pects. Journal of Virology 66: 6008–6018.
PACKER, C., S. ALTIZER, M. J. APPEL, E. W. BROWN, J.
S. MARTENSON, S. J. O’BRIEN, M. ROELKE-
PARKER, R. HOFMANN-LEHMANN, AND H. LUTZ.
1999. Viruses of the Serengeti: Patterns of
infection and mortality in African lions. Journal
of Animal Ecology 68: 1161–1178.
PEDERSEN, N. C., E. W. HO, M. L. BROWN, AND J. K.
YAMAMOTO. 1987. Isolation of a T-lymphotropic
virus from domestic cats with an immunodefi-
ciency-like syndrome. Science 235: 790–793.
———, J. K. YAMAMOTO, T. ISHIDA, AND H. HANSEN.
1989. Feline immunodeficiency virus infection.
Veterinary Immunology and Immunopathology
POLI, A., F. ABRAMO, P. CAVICCHIO, P. BENDECCHI, E.
GHELARDI, AND M. PISTELLO. 1995. Lentivirus
infection in an African lion: A clinical, pathologic
and virologic study. Journal of Wildlife Diseases
PRINCE, A. M., H. REESINK, D. PASCUAL, B. HOROWITZ,
I. HEWLETT, K. K. MURTHY, K. E. COBB, AND J.
W. EICHBERG. 1991. Prevention of HIV infection
by passive immunization with HIV immunoglob-
ulin. AIDS Research and Human Retroviruses 7:
ROELKE ET AL.—T-LYMPHOCYTE PROFILES IN LIONS AND PUMAS 247
ROELKE, M. E., D. J. FORRESTER, E. R. JACOBSON, G.
V. KOLLIAS, F. W. SCOTT, M. C. BARR, J. F.
EVERMANN, AND E. C. PIRTLE. 1993. Seropreva-
lence of infectious disease agents in free-ranging
Florida panthers (Felis concolor coryi). Journal
of Wildlife Diseases 29: 36–49.
ROELKE-PARKER, M. E., L. MUNSON, C. PACKER, R.
KOCK, S. CLEAVELAND, M. CARPENTER, S. J.
O’BRIEN, A. POSPISCHIL, R. HOFMANN-LEHMANN,
AND H. LUTZ. 1996. A canine distemper virus
epidemic in Serengeti lions (Panthera leo).
Nature 379: 441–445.
SAS. 2001. SAS.SAS Institute, Cary, North
SHIMOJIMA, M., T. MIYAZAWA, M. KOHMOTO, Y. IKEDA,
Y. NISHIMURA, K. MAEDA, Y. TOHYA,
MIKAMI. 1998. Expansion of CD8alpha+beta2
cells in cats infected with feline immunodefi-
ciency virus. Journal of General Virology 79 (1):
SOKOL, R., AND F. ROHLF. 1991. Biometry. W. H.
Freeman, New York, 859 pp.
TERWEE, J. A., J. K. YACTOR, K. S. SONDGEROTH, AND
S. VANDEWOUDE. 2005. Puma lentivirus is con-
trolled in domestic cats after mucosal exposure
in the absence of conventional indicators of
immunity. Journal of Virology 79: 2797–2806.
TROYER, J. L., J. PECON-SLATTERY, M. E. ROELKE, L.
BLACK, C. PACKER, AND S. J. O’BRIEN. 2004.
Patterns of feline immunodeficiency virus mul-
tiple infection and genome divergence in a free-
ranging population of African lions. Journal of
Virology 78: 3777–3791.
———, ———, ———, W. JOHNSON, S. VANDE-
WOUDE, N. VAZQUEZ-SALAT, M. BROWN, L. FRANK,
R. WOODROFFE, C. WINTERBACH, H. WINTER-
BACH, G. HEMSON, M. BUSH, K. A. ALEXANDER,
E. REVILLA, AND S. J. O’BRIEN. 2005. Seropreva-
lence and genomic divergence of circulating
strains of feline immunodeficiency virus among
Felidae and Hyaenidae species. Journal of
Virology 79: 8282–8294.
VANDEWOUDE, S., C. L. HAGEMAN, AND E. A. HOOVER.
2003. Domestic cats infected with lion or
puma lentivirus develop anti-feline immunode-
ficiency virus immune responses. Journal of
Acquired Immune Deficiency Syndrome 34:
———, S. J. O’BRIEN, AND E. A. HOOVER. 1997a.
Infectivity of lion and puma lentiviruses for
domestic cats. Journal of General Virology
78 (4): 795–800.
———, ———, K. LANGELIER, W. D. HARDY, J. P.
SLATTERY, E. E. ZUCKERMAN, AND E. A. HOOVER.
1997b. Growth of lion and puma lentiviruses in
domestic cat cells and comparisons with FIV.
Virology 233: 185–192.
WILLETT, B. J., M. J. HOSIE, J. J. CALLANAN, J. C.
NEIL, AND O. JARRETT. 1993. Infection with feline
immunodeficiency virus is followed by the rapid
expansion of a CD8+ lymphocyte subset. Im-
munology 78: 1–6.
———, E. SPARGER, E. W. HO, P. R. ANDERSEN, AND
T. P. O’CONNOR. 1988. Pathogenesis of experi-
mentally induced feline immunodeficiency virus
infection in cats. American Journal of Veterinary
Research 49: 1246–1258.
YAMAMOTO, J. K., E. SPARGER, E. W. HO, P. R.
ANDERSEN, T. P. O’CONNOR, C. P. MANDELL, L.
LOWENSTINE, R. MUNN, AND N. C. PEDERSEN.
1988. Pathogenesis of experimentally induced
feline immunodeficiency virus infection in cats.
American Journal of Veterinary Research 49:
———, H. HANSEN, AND E. W. HO, T. Y. MORISHITA,
T. OKUDA, T. R. SAWA, R. M. NAKAMURA, AND N.
C. PEDERSEN. 1989. Epidemiologic and clinical
aspects of feline immunodeficiency virus in-
fection in cats from the continental United
States and Canada and possible mode of trans-
mission. Journal of the American Veterinary
Medical Association 194: 213–220.
Received for publication 13 October 2004.
248JOURNAL OF WILDLIFE DISEASES, VOL. 42, NO. 2, APRIL 2006